Smart Stapler
Tissue assessment and structure identification for stapling procedures
Key Facts
About Briteseed
Briteseed is pioneering the integration of hyperspectral imaging into laparoscopic and robotic surgical instruments, aiming to reduce intraoperative complications by providing real-time, actionable tissue data. Founded in 2012 and based in Chicago, the company is developing a suite of smart tools, including advanced energy, stapler, and dissection devices, that work within current surgical workflows without requiring instrument swaps. Its core value proposition is enhancing surgeon decision-making by dynamically revealing anatomical structures and tissue quality that are not visible to the naked eye. As a private, pre-revenue company, Briteseed is positioned to address a significant unmet need in the growing minimally invasive and robotic surgery markets.
View full company profile